Glutamine: role in critical illness and ongoing clinical trials
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: This review will assess recent clinical and mechanistic data examining glutamine's ability to reduce morbidity and mortality in critical illness. RECENT FINDINGS: Updated metaanalysis data reveal a significant benefit of glutamine supplementation on mortality, length of stay, and infectious morbidity in critical illness. Recent data support glutamine's use in critically ill patients requiring parenteral nutrition and new data reveal safety and efficacy in head-injured patients. Further, new findings on glutamine's beneficial effect on insulin resistance in critical illness will be reviewed. Recent laboratory data have clarified a number of key mechanistic pathways by which glutamine may improve outcome in critical illness. SUMMARY: Severe glutamine deficiencies occur rapidly in critical illness. The magnitude of glutamine deficiency is correlated with ICU mortality. Further, metaanalysis reveals glutamine reduces morbidity and mortality in critical illness. It is likely that our new understanding of the molecular pathways by which glutamine acts will lead to insight on how best to utilize glutamine as a nutritional therapy. Presently, randomized, multicenter clinical trials utilizing glutamine as both nutritional replacement and pharmacologic intervention, independent of nutritional needs, are ongoing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841 · cited 2×
“Furthermore, the total number of sepsis-induced hospital deaths has continued to increase over time [ 47 ], increasing more than 90% in the last 20years [48].”
BackgroundInfluentialIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Is Glutamine a Conditionally Essential Amino Acid?
Lacey, J. M., & Wilmore, D. W. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1990.tb02967.x · Cited by 808 · cited 1×
“Glutamine is now considered by many investigators to be ‘conditionally essential’ in critical illness [ 10 ].”
BackgroundHoudijk, A. P., Rijnsburger, E. R., Jansen, J., Wesdorp, R. I., Weiss, J. K., McCamish, M. A., Teerlink, T., Meuwissen, S. G., Haarman, H. J. T. M., Thijs, L. G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02007-8 · Cited by 620
Bakalar, B., Duska, F., Pachl, J., Fric, M., Otahal, M., Pazout, J., & Andel, M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000196829.30741.d4 · Cited by 136
Glutamine, gene expression, and cell function
Curi, R. (2007) · Frontiers in Bioscience · doi:10.2741/2068 · Cited by 135
Cited by
Immunonutrition in critically ill patients: a systematic review and analysis of the literature
Marik, P. E., & Zaloga, G. P. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1213-6 · Cited by 295
Parenteral Nutrition in the Critically Ill Patient
Ziegler, T. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmct0806956 · Cited by 252
Parenteral glutamine supplementation in critical illness: a systematic review
Wischmeyer, P. E., Dhaliwal, R., McCall, M., Ziegler, T. R., & Heyland, D. K. (2014) · Critical Care · doi:10.1186/cc13836 · Cited by 175
“; licensee BioMed Ce Creative Commons Attribution License (http:/ distribution, and reproduction in any medium revealed that following illness and injury, GLN plays a vital role in inducing cellular protection pathways, modulation of the inflammatory response, and prevention of organ injury [1].”
InfluentialSelf-citationPharmaconutrition Review: Physiological Mechanisms
Pierre, J. F., Heneghan, A. F., Lawson, C. M., Wischmeyer, P. E., Kozar, R. A., & Kudsk, K. A. (2013) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607113493326 · Cited by 51
Self-citationTherapeutic benefits of glutamine: An umbrella review of meta-analyses
McRae, M. P. (2017) · Biomedical Reports · doi:10.3892/br.2017.885 · Cited by 39
Metadata
- Authors
- Wischmeyer, P. E.
- Venue
- Current Opinion in Gastroenterology
- Published
- 2008-03
- Volume
- 24
- Issue
- 2
- Pages
- 190-197
- ISSN
- 0267-1379 (ISSN-L)
- OpenAlex
- W2060139051
- Cited by
- 124
- References
- 7
- FWCI
- 12.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glutamine: role in critical illness and ongoing clinical trials. https://app.cochat.ai/papers/10.1097/mog.0b013e3282f4db94
- The paper
- Wischmeyer, P. E. (2008). Glutamine: role in critical illness and ongoing clinical trials. Current Opinion in Gastroenterology. https://doi.org/10.1097/mog.0b013e3282f4db94
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.